Silexan for treatment of anxiety and depression in the context of COVID-19.

Bartova, Lucie; Dold, Markus; Fugger, Gernot; Weidenauer, Ana; Rujescu, Dan; Kasper, Siegfried

Bartova, Lucie; Dold, Markus; Fugger, Gernot; Weidenauer, Ana; Rujescu, Dan; Kasper, Siegfried.

Bartova L; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
Dold M; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
Fugger G; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria; Psychiatric Day Hospital, University Hospital St. Poelten, St. Poelten, Austria; Karl Landstein
Weidenauer A; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
Rujescu D; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
Kasper S; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria; Center for Brain Research, Medical University of Vienna, Vienna, Austria. Electronic address: s

Eur Neuropsychopharmacol ; 70: 47-48, 2023 05.

Article in English | MEDLINE | ID: covidwho-2251372

Subject(s)

COVID-19; Oils, Volatile; Humans; Depression/drug therapy; Plant Oils/pharmacology; Plant Oils/therapeutic use; Oils, Volatile/pharmacology; Oils, Volatile/therapeutic use; Anxiety/drug therapy

Keywords

Anxiety; COVID-19; Depression; Psychosomatic; Silexan; Subsyndromal

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Oils, Volatile / COVID-19 Limits: Humans Language: English Journal: Eur Neuropsychopharmacol Journal subject: Psychopharmacology Year: 2023 Document Type: Article Affiliation country: J.euroneuro.2023.02.015

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google